vaccine
-
COVID-19 Plant Extract: Clinical Trial Begins For Vaccine Made From Tobacco Plant
Scientists all over the country are testing a new two-dose COVID-19 vaccine candidate that is based on plants. Produced by Medicago vaccination, a biopharmaceutical company in Canada, the shot makes use of tobacco shrub.
Latest Research Articles
-
California Doctor Skeptical Of Vaccines Put On Probation By Medical Board
-
This Vaccine Could Protect You From Acnes
-
Is it Right to Sequence DNA of Newborns? Experts Weigh in on Benefits, Consequences
-
WARNING: Almost Half of Men in the US have Genital HPV Infections
-
Scientists Have Developed an OFFICIAL Ebola Vaccine With 100-Percent Efficiency
-
WHO: Microcephaly-Causing Zika Virus No Longer a World Health Emergency
-
Zika Update: Promising Army-Developed Zika Vaccine Enters Clinical Trials
-
Future of Vaccines! Scientists Create 'Universal Flu Vaccine' That Could Prevent Millions of Deaths
-
Say What? Doctor Caught Using Cat Saliva, Vodka for His Vaccines
-
Scientists Develop First Widely Protective Vaccine Against Chlamydia
-
MIT’s Customizable RNA Vaccine Allows For Rapid Deployment to Ebola-Stricken Areas
-
Zika Update: First Zika Vaccine Ready for Human Trial
